<DOC>
	<DOCNO>NCT00049296</DOCNO>
	<brief_summary>RATIONALE : Thalidomide may stop growth cancer stop blood flow tumor . Drugs use chemotherapy use different way stop cancer cell divide stop grow die . Combining thalidomide docetaxel may kill tumor cell . PURPOSE : Phase I trial study effectiveness combine thalidomide docetaxel treat patient advanced cancer .</brief_summary>
	<brief_title>Thalidomide Docetaxel Treating Patients With Advanced Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine maximum tolerate dose docetaxel administer thalidomide patient advance solid tumor , multiple myeloma , non-Hodgkin 's lymphoma . - Determine dose-limiting toxicity safety profile regimen patient . - Determine plasma pharmacokinetics regimen patient . - Determine objective tumor response prolong freedom progression patient treat regimen . OUTLINE : This dose-escalation study . Patients receive oral thalidomide twice daily docetaxel IV 30 minute weekly . Courses repeat every 12 week absence disease progression unacceptable toxicity . Cohorts 3-6 patient receive escalate dos docetaxel thalidomide maximum tolerate dose ( MTD ) determine . The MTD define dose precede 1 3 2 6 patient experience dose-limiting toxicity . PROJECTED ACCRUAL : A total 3-30 patient accrue study .</detailed_description>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Thalidomide</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm malignancy amenable curative surgery , radiotherapy , chemotherapy Tumor type may include follow : Any solid tumor include , limited , head neck , breast , lung , gastrointestinal , genitourinary , melanoma , sarcoma Primary CNS neoplasm follow true : Received primary radiotherapy No concurrent corticosteroid stable corticosteroid dose least 30 day No concurrent enzymeinducible antiepileptic medication ( i.e. , carbamazepine phenytoin ) Multiple myeloma NonHodgkin 's lymphoma No refractory relapse acute chronic leukemia Measurable evaluable disease No lifeprolonging therapy available Hormone receptor status : Not specify PATIENT CHARACTERISTICS : Age 18 Sex Male female Menopausal status Not specify Performance status ECOG 01 Life expectancy At least 4 month Hematopoietic WBC least 4,000/mm^3 Absolute neutrophil count least 1,500/mm^3 Platelet count least 100,000/mm^3 Hemoglobin least 10 g/dL Hepatic Bilirubin great upper limit normal ( ULN ) AST and/or ALT great 2.5 time ULN alkaline phosphatase less ULN OR Alkaline phosphatase great 4 time ULN AST/ALT less ULN Renal Creatinine great 1.5 mg/dL OR Creatinine clearance least 60 mL/min Cardiovascular No New York Heart Association class III IV heart disease Other Not pregnant nursing Negative pregnancy test Fertile patient must use 2 effective method contraception 4 week , , 4 week study Willing able comply FDAmandated STEPS program No peripheral neuropathy grade 2 great No prior severe hypersensitivity reaction docetaxel drug formulate polysorbate 80 PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy At least 3 week since prior chemotherapy ( 6 week nitrosoureas mitomycin ) recover No 2 prior course mitomycin Endocrine therapy See Disease Characteristics Radiotherapy At least 4 week since prior largefield radiotherapy recover Surgery Not specify Other At least 3 week since prior anticancer therapy recover</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>adult anaplastic astrocytoma</keyword>
	<keyword>male breast cancer</keyword>
	<keyword>adult anaplastic oligodendroglioma</keyword>
	<keyword>adult meningeal hemangiopericytoma</keyword>
	<keyword>adult brain stem glioma</keyword>
	<keyword>adult central nervous system germ cell tumor</keyword>
	<keyword>adult choroid plexus tumor</keyword>
	<keyword>adult craniopharyngioma</keyword>
	<keyword>adult ependymoblastoma</keyword>
	<keyword>adult glioblastoma</keyword>
	<keyword>adult pilocytic astrocytoma</keyword>
	<keyword>adult anaplastic ependymoma</keyword>
	<keyword>adult medulloblastoma</keyword>
	<keyword>adult meningioma</keyword>
	<keyword>adult pineoblastoma</keyword>
	<keyword>adult pineocytoma</keyword>
	<keyword>adult subependymoma</keyword>
	<keyword>adult myxopapillary ependymoma</keyword>
	<keyword>advanced adult primary liver cancer</keyword>
	<keyword>anterior urethral cancer</keyword>
	<keyword>carcinoma appendix</keyword>
	<keyword>chondrosarcoma</keyword>
	<keyword>classic Kaposi sarcoma</keyword>
	<keyword>AIDS-related Kaposi sarcoma</keyword>
	<keyword>immunosuppressive treatment relate Kaposi sarcoma</keyword>
	<keyword>recurrent Kaposi sarcoma</keyword>
	<keyword>clear cell sarcoma kidney</keyword>
	<keyword>disseminate neuroblastoma</keyword>
	<keyword>extensive stage small cell lung cancer</keyword>
	<keyword>gastrointestinal stromal tumor</keyword>
	<keyword>metastatic gastrointestinal carcinoid tumor</keyword>
	<keyword>metastatic osteosarcoma</keyword>
	<keyword>metastatic transitional cell cancer renal pelvis ureter</keyword>
	<keyword>metastatic Ewing sarcoma/peripheral primitive neuroectodermal tumor</keyword>
	<keyword>adult mixed glioma</keyword>
	<keyword>ovarian sarcoma</keyword>
	<keyword>posterior urethral cancer</keyword>
	<keyword>primary central nervous system lymphoma</keyword>
	<keyword>pulmonary carcinoid tumor</keyword>
	<keyword>recurrent adenoid cystic carcinoma oral cavity</keyword>
	<keyword>recurrent adult brain tumor</keyword>
	<keyword>recurrent adult diffuse large cell lymphoma</keyword>
	<keyword>recurrent adult diffuse mixed cell lymphoma</keyword>
	<keyword>recurrent adult diffuse small cleave cell lymphoma</keyword>
	<keyword>recurrent adult Burkitt lymphoma</keyword>
	<keyword>recurrent adult immunoblastic large cell lymphoma</keyword>
	<keyword>recurrent adult lymphoblastic lymphoma</keyword>
	<keyword>recurrent adult primary liver cancer</keyword>
	<keyword>recurrent adult soft tissue sarcoma</keyword>
	<keyword>recurrent anal cancer</keyword>
	<keyword>recurrent basal cell carcinoma lip</keyword>
	<keyword>recurrent bladder cancer</keyword>
	<keyword>recurrent breast cancer</keyword>
	<keyword>recurrent colon cancer</keyword>
	<keyword>recurrent esophageal cancer</keyword>
	<keyword>recurrent esthesioneuroblastoma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent extrahepatic bile duct cancer</keyword>
	<keyword>recurrent gallbladder cancer</keyword>
	<keyword>recurrent gastric cancer</keyword>
	<keyword>recurrent gastrointestinal carcinoid tumor</keyword>
	<keyword>recurrent grade 1 follicular lymphoma</keyword>
	<keyword>recurrent grade 2 follicular lymphoma</keyword>
	<keyword>recurrent grade 3 follicular lymphoma</keyword>
	<keyword>recurrent invert papilloma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent lymphoepithelioma nasopharynx</keyword>
	<keyword>recurrent lymphoepithelioma oropharynx</keyword>
	<keyword>recurrent mantle cell lymphoma</keyword>
	<keyword>recurrent melanoma</keyword>
	<keyword>recurrent metastatic squamous neck cancer occult primary</keyword>
	<keyword>recurrent midline lethal granuloma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent mucoepidermoid carcinoma oral cavity</keyword>
	<keyword>recurrent neuroblastoma</keyword>
	<keyword>recurrent non-small cell lung cancer</keyword>
	<keyword>recurrent osteosarcoma</keyword>
	<keyword>recurrent pancreatic cancer</keyword>
	<keyword>recurrent rectal cancer</keyword>
	<keyword>recurrent renal cell cancer</keyword>
	<keyword>recurrent small cell lung cancer</keyword>
	<keyword>recurrent small intestine cancer</keyword>
	<keyword>recurrent squamous cell carcinoma hypopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma larynx</keyword>
	<keyword>recurrent squamous cell carcinoma lip oral cavity</keyword>
	<keyword>recurrent squamous cell carcinoma nasopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma oropharynx</keyword>
	<keyword>recurrent squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>recurrent transitional cell cancer renal pelvis ureter</keyword>
	<keyword>recurrent Ewing sarcoma/peripheral primitive neuroectodermal tumor</keyword>
	<keyword>recurrent urethral cancer</keyword>
	<keyword>recurrent uterine sarcoma</keyword>
	<keyword>recurrent verrucous carcinoma larynx</keyword>
	<keyword>recurrent verrucous carcinoma oral cavity</keyword>
	<keyword>refractory multiple myeloma</keyword>
	<keyword>rhabdoid tumor kidney</keyword>
	<keyword>small intestine adenocarcinoma</keyword>
	<keyword>small intestine leiomyosarcoma</keyword>
	<keyword>small intestine lymphoma</keyword>
	<keyword>stage II esophageal cancer</keyword>
	<keyword>stage II pancreatic cancer</keyword>
	<keyword>stage III esophageal cancer</keyword>
	<keyword>stage III multiple myeloma</keyword>
	<keyword>stage III pancreatic cancer</keyword>
	<keyword>stage IV adenoid cystic carcinoma oral cavity</keyword>
	<keyword>stage IV adult diffuse large cell lymphoma</keyword>
	<keyword>stage IV adult diffuse mixed cell lymphoma</keyword>
	<keyword>stage IV adult diffuse small cleave cell lymphoma</keyword>
	<keyword>stage IV adult Burkitt lymphoma</keyword>
	<keyword>stage IV adult immunoblastic large cell lymphoma</keyword>
	<keyword>stage IV adult lymphoblastic lymphoma</keyword>
	<keyword>stage IV anal cancer</keyword>
	<keyword>stage IV basal cell carcinoma lip</keyword>
	<keyword>stage IV bladder cancer</keyword>
	<keyword>stage IV breast cancer</keyword>
	<keyword>stage IV colon cancer</keyword>
	<keyword>stage IV esophageal cancer</keyword>
	<keyword>stage IV esthesioneuroblastoma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV gastric cancer</keyword>
	<keyword>stage IV grade 1 follicular lymphoma</keyword>
	<keyword>stage IV grade 2 follicular lymphoma</keyword>
	<keyword>stage IV grade 3 follicular lymphoma</keyword>
	<keyword>stage IV invert papilloma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV lymphoepithelioma nasopharynx</keyword>
	<keyword>stage IV lymphoepithelioma oropharynx</keyword>
	<keyword>stage IV mantle cell lymphoma</keyword>
	<keyword>stage IV melanoma</keyword>
	<keyword>stage IV midline lethal granuloma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV mucoepidermoid carcinoma oral cavity</keyword>
	<keyword>stage IV non-small cell lung cancer</keyword>
	<keyword>stage IV rectal cancer</keyword>
	<keyword>stage IV renal cell cancer</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma larynx</keyword>
	<keyword>stage IV squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IV squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IV squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV uterine sarcoma</keyword>
	<keyword>stage IV verrucous carcinoma larynx</keyword>
	<keyword>stage IV verrucous carcinoma oral cavity</keyword>
	<keyword>unresectable extrahepatic bile duct cancer</keyword>
	<keyword>unresectable gallbladder cancer</keyword>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
	<keyword>urethral cancer associate invasive bladder cancer</keyword>
	<keyword>recurrent salivary gland cancer</keyword>
	<keyword>stage IV salivary gland cancer</keyword>
	<keyword>recurrent marginal zone lymphoma</keyword>
	<keyword>recurrent small lymphocytic lymphoma</keyword>
	<keyword>stage IV small lymphocytic lymphoma</keyword>
	<keyword>stage IV marginal zone lymphoma</keyword>
	<keyword>extranodal marginal zone B-cell lymphoma mucosa-associated lymphoid tissue</keyword>
	<keyword>nodal marginal zone B-cell lymphoma</keyword>
	<keyword>splenic marginal zone lymphoma</keyword>
	<keyword>stage IV adult soft tissue sarcoma</keyword>
	<keyword>adult grade III meningioma</keyword>
	<keyword>adult oligodendroglioma</keyword>
	<keyword>adult giant cell glioblastoma</keyword>
	<keyword>adult gliosarcoma</keyword>
	<keyword>stage IV pancreatic cancer</keyword>
</DOC>